HOLLOW-TUBE BRACHYTHERAPY DEVICE

Abstract: A novel brachytherapy device is disclosed that is formed from a hollow-tube-shaped seed-substrate, allowing the easy association of the device with suture material. This shape minimizes the chance of migration of implanted seeds due to better attachment to tissue. The distribution of the radioactive material on the exterior surface of the tubular device provides a relatively uniform radiation field around the hollow-tube-shaped brachytherapy seed source. Brachytherapy devices are disclosed that are inherently radioactive. Also disclosed are devices that can be rendered radioactive by the transmuting effects of neutron irradiation. Brachytherapy devices are disclosed that facilitate medical application and improve safety for patients and medical personnel.

Description: HOLLOW-TUBE BRACHYTHERAPY DEVICE Technical Field The invention disclosed herein relates to radioactive implants for medical therapeutic purposes, referred to in the art as "radioactive seeds," "seeds," or "sources ' The invention relates to seeds for therapeutic radiation treatment of oncological and other medical conditions More particularly, the invention is directed to a novel radioactive seed for interstitial implantation brachytherapy and also for general brachytherapy treatments The invention is also directed to methods of making the seeds and methods of using the seeds Background Art The localized treatment of tumors and other medical conditions by the interstitial implantation of radioactive materials is a recognized treatment modality of long standing Radioactive implants are used to provide radiation therapy in order to reduce or prevent the growth of tumors that cannot be removed by surgical means Radioactive implants are also used to prevent the growth of microscopic metastatic deposits in lymph nodes that drain the region where a tumor has been removed Implants are also used to irradiate the postoperative tumor bed after the tumor is excised Implantation of radioactive sources di¬ rectly into solid tumors for the destruction of the tumors is used in a therapy referred to as brachytherapy Brachytherapy is also used to prevent the regrowth of tissue in circumstances such as the treatment of arteries for occlusive disease Brachytherapy is apphed, for example, in the treatment of atherosclerosis to inhibit restenosis of blood vessels after balloon- angioplasty or other treatments to open occluded or narrowed vessels These brachytherapy treatments involve a short-term application of extremely radioactive sources The applications can be for periods as short as a few minutes This form of brachytherapy may therefore be contrasted with the treatment of tumors where lower activity sources are used for longer periods of time that may be measured in hours or days or may involve permanent implantation Treatment of medical conditions with the local application of radiation by implantation concentrates the treatment on the adjacent tissue and advantageously minimizes the exposure of more distant tissues that it is not desired to irradiate Direct implantation of radioactive sources into tumors often permits the application of larger doses of radiation than may otherwise be achieved because the radiation is applied directly at the site to be irradiated Local application of brachytherapy to non-cancerous conditions also allows the use of more intensive treatment than is possible by other means In the pnor art, brachytherapy "sources" are generally implanted for short periods of time and usually are sources of high radiation intensity For example, irradiation of body cavities such as the uterus has been achieved by placing radιum-226 capsules or cesium- 137 capsules in the lumen of the organ In another example, tumors have been treated by the surgical insertion of radium needles or ιndιum-192 ribbons into the body of the tumor In yet other instances gold- 198 or radon-222 have been used as radioactive sources These isotopes require careful handling because they emit highly energetic and penetrating radiation that can cause significant exposure to medical personnel and to the normal tissues of the patient undergoing therapy Therapy with sources of this type requires that hospitals build shielded rooms, provide medical personnel with appropriate protection and establish protocols to manage the radiation hazards The prior art interstitial brachytherapy treatment using needles or ribbons has features that inevitably irradiate normal tissues For example, normal tissue surrounding the tumor is irradiated when a high energy isotope is used even though the radiation dose falls as the square of the distance from the source Brachytherapy with devices that utilize radιum-226, cesιum-137 or ιrιdιum-192 is hazardous to both the patient and the medical personnel involved because of the high energy of the radioactive emissions The implanted radioactive objects can only be left in place temporarily, thus the patient must undergo both an implantation and removal procedure Medical personnel are thus twice exposed to a radiation hazard In prior art brachytherapy that uses long-term or permanent implantation, the radioactive device is usually referred to as a "seed " Where the radiation seed is implanted directly into the diseased tissue, this form of therapy is referred to as interstitial brachytherapy It may be distinguished from intracavitary therapy, where the radiation seed or source is arranged in a suitable applicator to irradiate the walls of a body cavity from the lumen Migration of the device away from the site of implantation is a problem sometimes encountered with presently available ιodme-125 and palladιum-103 permanently implanted brachytherapy devices because no means of affirmatively localizing the device may be available The prior art discloses iodine seeds that can be temporarily or permanently implanted The iodine seeds disclosed in the prior art consist of the radionuchde adsorbed onto a carrier that is enclosed within a welded metal tube Seeds of this type are relatively small and usually a large number of them are implanted in the human body to achieve a therapeutic effect Individual seeds of this kind described m the prior art also intrinsically produce an mhomogeneous radiation field due to the form of the construction The prior art also discloses sources constructed by enclosing indium metal in plastic tubmg These sources are then temporarily implanted mto accessible tissues for time periods of hours or days These sources must be removed and, as a consequence, their application is limited to readily accessible body sites Prior art seeds typically are formed in a manner that differs from isotope to isotope The form of the prior art seeds is thus tailored to the particular characteristics of the isotope to be used Therefore, a particular type of prior art seed provides radiation only in the narrow range of energies available from the particular isotope used Brachytherapy seed sources are disclosed m, for example, U S patent 5,405,165 to Carden, U S patent 5,354,257 to Roubin, U S patent 5,342,283 to Good, U S patent 4,891,165 to Suthanthinan, U S patent 4,702,228 to Russell et al, U S patent 4,323,055 to Kubiatowicz and U S patent 3,351,049 to Lawrence, the disclosures of which are incorporated herem by reference The brachytherapy seed source disclosed by Carden compnses small cylinders or pellets on which palladium- 103 compounded with non-radioactive palladium has been applied by electroplating Addition of palladium to palladium- 103 permits electroplating to be achieved and allows adjustment of the total activity of the resulting seed The pellets are placed inside a titanium tube, both ends of which are sealed The disclosed invention does not provide means to fix the seed source within the tissues of the patient to ensure that the radiation is correctly delivered The design of the seed source is such that the source produces an asymmetncal radiation field due to the radioactive material being located only on the pellets The patent also discloses the use of end caps to seal the tube and the presence of a radiographically detectable marker inside the tube between the pellets The patent to Roubin relates to radioactive indium metal brachytherapy devices positioned at the end of minimally invasive intravascular medical devices for providing radiation treatment in a body cavity Flexible elongated members are disclosed that can be inserted through catheters to reach sites where radiation treatment is desired to be applied that can be reached via vessels of the body The patent to Good discloses methods such as sputtering for applying radioactive metals to solid manufactured elements such as microspheres, wires and ribbons The disclosed methods are also disclosed to apply protective layers and identification layers Also disclosed are the resulting solid, multilayered, seamless elements that can be implanted individually or combined in intracavitary application devices The patent to Suthanthinan relates to the production of brachytherapy seed sources and discloses a technique for use in the production of such sources The patent discloses an encapsulation technique employing two or more interfitting sleeves with closed bottom portions The open end portion of one sleeve is designed to accept the open end portion of a second slightly-smaller-diameter sleeve The patent discloses the formation of a sealed source by sliding two sleeves together Seeds formed by the Suthanthinan process may have a more uniform radiation field than the seed disclosed by Carden However, the seed disclosed by Suthanthinan provides no means for securely locating the seed in the tissue of the patient The patent to Russell et al relates to the production of brachytherapy seed sources produced by the transmutation of isotopically enriched palladιum-102 to palladιum-103 by neutrons produced by a nuclear reactor The Russell patent also discloses a titanium seed with sealed ends, similar to that of Carden, containing a multiplicity of components A seed produced in this manner is associated with yielding a less than isotropic radiation field The patent to Kubiatowicz teaches a titanium seed with ends sealed by laser, electron beam or tungsten inert gas welding The radioactive component of the seed is disclosed to be a silver bar onto which the radioisotope iodine- 125 is chemisorbed Seeds produced in this manner also tend to produce an asymmetric radiation field and provide no means of attachment to the site of application in the patient The patent to Lawrence discloses a radioactive seed with a titanium or plastic shell with sealed ends Seeds are disclosed containing a variety of cylindncal or pellet components onto which one of the radioisotopes ιodιne-125, palladιum-103, ιndιum-192 or cesιum-131 is incorporated The structure of the disclosed seeds yields a non-homogeneous radiation field and provides no means for accurately positioning the seed in the tissue that it is desired to irradiate Currently available brachytherapy seeds do not easily lend themselves to association with suture matenal For example, iodine- 125 seeds currently in use are placed inside suture matenal at the time of manufacture However, the insertion process is tedious and time consuming and has the potential for significant radiation exposure to the production personnel involved Additionally, because of the natural decay of the radioisotope, the suture material thus produced has a short shelf life As a second example, the manufacturing process used to produce the palladium- 103 seeds that are currently in use results in end-roughness of the encapsulation of the seed The capsules are not placed inside suture material because the end-roughness makes insertion very difficult Rigid rods are produced m present technology by the insertion of seeds into suture material followed by heat treatment to form a rigid rod containing the seed These rods are difficult to produce, very fragile and sensitive to moisture The presently available brachytherapy technology requires that most physicians use suture material preassembled with the seeds already inside Similarly, rigid materials used by surgeons for brachytherapy are pre-manufactured and purchased readymade Disclosure of Invention The present invention provides a novel general-use brachytherapy device for the interstitial radiotherapy of malignant neoplasms or other diseases treatable with radiation The device of the instant invention comprises a hollow tubular support with a lumen that is open on both ends The tubular support of the device bears a radioactive layer that is enclosed with a sealing layer to prevent contact between the radioactive matenal and the tissues and fluids of the patient The hollow tubular support of the present invention comprises a hollow-tube-shaped seed-substrate that has internal and external surfaces Other embodiments of the instant invention have perforations through the walls of the hollow tube In embodiments that have perforations through the walls of the tube, the perforations may be oπented in any direction The various elements of the device may be made of titanium or other biocompatible metal or may be made of synthetic matenal such as plastic The radioactive source material is disposed as a layer on the external surface of the tube of the device Other materials, such as radiographically detectable material, may also be layered on the external surface of the tube of the device The entire device is provided with a biologically-compatible, radiation-permeable, surface-sealing layer that entirely seals the external surface of the tube An object of the mvention disclosed herem is to provide for the improved treatment of medical conditions such as neoplastic diseases according to the normal practice of brachytherapy, e g , the interstitial implantation of radioactive sources into tumorous tissue for the purpose of irradiating and thus killing malignant cells An object of the invention disclosed herein is to provide a brachytherapy device specifically intended to ease the task of surgeons, urologists, radiation therapists, radiologists and others who use brachytherapy devices in providing treatment to patients The hollow tubular design promotes simple and efficient interaction between the device and suture materials commonly used in surgery Simply stated, the hollow-tube-shaped form of the device disclosed herein permits suture material, rigid rods or other biocompatible connecting members to be passed through it in such a way as to fix its position relative to the treatment volume The suture material, rigid rod or other biocompatible connecting member may be threaded through the device at the time of surgery and can also serve to locate the device relative to other similar devices This flexibility allows a surgeon to effectively react to challenges not revealed by the pre-surgical work-up of the patient The design of the invention disclosed herein promotes simple and efficient interaction between the device and suture mateπais commonly used in surgery Thus, the brachytherapy device disclosed herein has special application to the form of brachytherapy wherein seeds are associated with flexible suture material and are thereby held in a compliant array in the neoplastic tissue by the suture while their radiation dose is delivered This greatly speeds and simplifies the process of applying the brachytherapy device, greatly improves the accuracy of emplacement in the tumor and reduces the hazard to which medical personnel are exposed The hollow-tube feature of the invention disclosed herein also has special application to the form of brachytherapy in which seeds are associated with a ngid, biocompatible material which holds the seeds in a fixed array in the neoplastic tissue while their radiation dose is delivered In a similar manner to that described above the disclosed device may be simply threaded onto any commonly used rigid support material to yield a suitable array For example a hollow-tube brachytherapy device as disclosed herein may be apphed by threading a surgical stainless-steel wire or plastic surgical filament through the lumen The threaded material may then be used to fix the device to the catheter The catheter is then used to position the array at a site where brachytherapy is needed The most preferred overall dimensions of the device disclosed herein may be a diameter of approximately 0 8 mm and a length of approximately 4 5 mm The advantage of providing a seed in these dimensions is that the device of the present invention may be implanted using currently available instruments Thus, the need for retooling by the therapist may be avoided, and a brachytherapy device that incorporates the seed-substrate of the instant invention may be applied without modification of current surgical practices Alternatively, the dimensions of the seed-substrate may be different from those disclosed above, depending upon the specific use to which the device is to be put Such different dimensions will be apparent to those of skill in the art The devices disclosed herein are designed to deliver a therapeutic dose of radiation to a spatially well defined and limited volume of diseased tissue within a living body Such a device is shaped as a hollow tube so that a suture material, rigid rod or other biocompatible connecting member passed through it can be used to fix its position relative to other similar devices The threaded connecting member can also serve to locate the device relative to the treatment volume The hollow-tube design of the device of the present invention also permits the growth of tissue into the device This tissue growth acts to anchor the device at the application site and minimize the potential for migration In embodiments of the device provided with perforations, the perforations also provide additional access for body fluids and tissues to the space mside the tube Another object of the invention disclosed herein is to provide an embodiment of the device that has its central tube-shaped substrate formed from a material that is essentially transparent to the radiation emitted by the therapeutic isotope Such material may be titanium, carbon, stainless-steel, tantalum, hafnium or zirconium The central tube may also be formed from plastics such as polypropylene, polyethylene terephthalate, nylon, polyurethane, polyphenylene oxide blends, polyphenylsulfone, polysulfone, polyether sulfone, polyphenylene sulfide, phenyletheretherketone, polyetheπmide or liquid crystal polymer The radioactive material of the embodiments of the invention of the disclosed herein is coated on the outer surface of the hollow-tube-shaped seed-substrate and is protected by the sealing layer Suitable radioisotopes are palladium- 103 or ιodιne-125 Other isotopes that emit radiation with the desired therapeutic properties can also be deposited over the outer surface of the tube in a uniform manner, for example gold-198, yttπum-90 and phosphorus-32 The radioactive material in this layer may already be radioactive when it is apphed such as by the application of palladιum-103 or ιodιne-125, or it may be applied as a precursor isotope such as gold- 197, yttrιum-89, indium- 191 or palladιum-102 that can be applied and then transmuted in situ, as disclosed in more detaii below In yet another embodiment of the instant invention a non-radioactive pre-seed is disclosed In this embodiment the layer of the device that will be radiation-emitting may be prepared by first plating the hollow-tube-shaped seed-substrate with a suitable non- radioactive isotope that may be transmuted in situ to the desired radiation-emitting isotope by bombardment with neutrons The material in this layer may be a precursor isotope such as gold-197, yttπum-89, ιπdιum-191 or palladιum-102 Upon neutron irradiation gold-197 is transmuted to 'gold-198" (which is actually a mixture of gold-198 and gold- 199) with a half- life of 2 7 days and with radiation-emitting properties suitable for brachytherapy For simplicity this isotope produced by this transmutation is referred to hereinafter as "gold- 198" Similar processes or transmutation can be used to produce yttnum-90 from yttnum-98 or palladium- 103 from palladium- 102 A particular advantage of this technique is that the time and intensity of the neutron irradiation can be adjusted to achieve a particular desired level of activity in the finished device The technique of neutron irradiation takes advantage of the fact that titanium and some other low-atomic-number metals have small nuclear cross-sections and are essentially unaffected by neutron irradiation A further advantage of this embodiment of the invention is that no radioactive material is used in the actual manufacturing of the device A third advantage is that manufactured devices may be stored indefinitely and may be rendered radioactive when needed by exposure to neutron irradiation from a nuclear reactor or cyclotron or other suitable source In such an embodiment of the invention, the transmutable non-radioactive isotope is first plated onto the hollow-tube-shaped seed-substrate Second, the plated hollow-tube seed-substrate is inserted into a closely fitting outer tube of the same length, or slightly longer if the outer tube is to be swaged, that provides the sealing layer This outer tube can be a metal such as titanium, and is made so that this sealing member or outer tube, fits snugly over the inner tube coated with the radioisotope and radiographically detectable band (if present) The ends of the inner and outer tubes are swaged together and joined, for example by laser welding, so as to form a sealed device The sealed device thus formed has the form of a double-walled tube The sealing layer may also be formed from stainless-steel, tantalum, hafnium or zirconium Alternatively, the outer tube can also be a synthetic matenal, such as one of the plastics mentioned above, made so that this sealing member or outer tube fits snugly over the inner tube coated with the radioisotope and radiographically-detectable band (if present) In the case of a plastic sealing member the ends of the inner and outer tubes can be sealed by standard techniques like gluing, heat sealing, solvent bonding or ultrasonic welding In yet another embodiment of the sealing layer of a material that is essentially transparent to the radiations emitted by the therapeutic isotope is deposited upon the surface For example, the sealing layer may be made of a material such as pyrolytic carbon deposited from a chemical vapor or such as titanium deposited from an atomic vapor The sealing layer may also be formed from carbon, tantalum, hafnium or zirconium, or may be formed from titanium carbide, titanium nitride, titanium carbonitπde, hafnium nitnde, or zirconium mtnde Alternatively, in another embodiment of the invention disclosed herein the sealing layer may consist essentially of an organic coating, as for example an organic coatmg formed from a heat-shπnkable plastic, a coating produced by solvent evaporation, a coating produced by a chemical polymerization reaction or a coating formed by molding plastic around the device Such organic coatings may be polypropylene, polyethylene terephthalate, nylon, polyurethane, polyphenylene oxide blends, polyphenylsulfone, polysulfone, polyether sulfone, polyphenylene sulfide, phenyletheretherketone, polyetherimide or liquid crystal polymer Another feature of the invention disclosed herein provides advantages in situations in which a remote afterloadmg technique is used For example, remote afterloading may be used with implants that are temporary implants in the brain The form of the brachytherapy device disclosed herein offers advantages because isotopes incorporated into these sources (palladιum-103 or ιodιne-125) emit X-rays of average energy between 21 and 30 keV A consequence of this low energy is to greatly simplify shielding For example, the half-value thickness (the thickness of lead required to reduce the dose rate from a source to 50%) is only 0 006 mm for palladιum-103 and 0 02 mm for ιodιne-125 Because the devices disclosed herein are simple to shield, most of the features normally associated with brachytherapy techniques that involve remote afterloading are not applicable Use of the devices disclosed herein would generally not require remote transfer of the radiation source from a shielded container into the tube implanted in the patient Similarly, the necessity to isolate the patient in a shielded room during treatment is generally avoided with the disclosed devices Isotopes incorporated into other embodiments of the device emit beta-particles rather than electromagnetic radiations These beta-particle emitting embodiments are advantageous in that they may also be effectively shielded by much smaller combinations of plastic and lead than those required by previously available afterloader sources Localization of sources following implantation is of importance because accurate knowledge of the position and orientation of the sources can confirm that they are in the positions specified in the medical treatment plan and consequently will provide a properly distributed radiation dose within the treatment volume To provide means whereby the device can be located after implantation, one embodiment of the present invention is formed with radiographically opaque material such as gold, platinum or other appropriate high- atomic-number element deposited on the device, preferably as a band on the surface near the center of the device This radiopaque material allows the visualization of the implanted device by standard radiographic procedures and allows the location and orientation to be accurately determined during treatment When the radioactive material is applied to an embodiment of the invention that bears a band of radiographically detectable material, the radioactive material may extend over the band of radiographically detectable matenal In another embodiment the radioactive material may extend only to within approximately 0 5 mm of the end edge of the tube-shaped seed-substrate and thus provide a narrow nonradioactive ring at each end of the device Generally, the radioactive material may be disposed on the device to suit many purposes that will be obvious to those of skill in the art In preferred embodiments of the present invention, a biocompatible sealing layer is deposited so that the entire external surfaces of the device are composed of a biocompatible material The sealing layer prevents radioactive materials from escaping and provides a radioactive device which meets the normal definition of a "sealed source " The sealing layer is made of a plastic matenal or any other biocompatible material, provided the matenal is adequately transparent to the therapeutic radiation and has sufficient durability to protect and retain the radioisotope underneath In another embodiment the sealing layer can be made of titanium or other suitable biocompatible metal that is adequately transparent to the therapeutic radiation The device disclosed herein will be used for the treatment of medical conditions such as neoplastic diseases according to the normal practice of brachytherapy, e g , the interstitial implantation of radioactive sources into tumorous tissue for the purpose of irradiating and thus killing malignant cells Other uses are the emplacement into vessels of the body, e g , to inhibit restenosis of blood vessels Brief Description of the Drawings Figure la shows a diagrammatic representation of a cross section of a device of the instant invention that is formed with a plastic sealing layer Figure lb shows a diagrammatic representation of a cross section of the end of the device shown in Figure la to reveal details of the interaction of the plastic sealing layer and the tube-shaped seed-substrate Figure 2a shows a diagrammatic representation of a cross section of an alternative device of the instant invention formed with a electroplated sealing layer Figure 2b shows a diagrammatic representation of a cross section of the end of the device shown in Figure 2a to reveal details of the interaction of the electroplated sealing layer and the tube-shaped seed-substrate Figure 3a shows a diagrammatic representation of a cross section of yet another device of the instant invention formed with an outer tube sealing layer Figure 3b shows a diagrammatic representation of a cross section of the end of the device shown in Figure 3a formed with an outer tube sealing layer to reveal details of the swaged and welded joint Figure 4 shows a perspective representation of devices of the instant invention disposed upon a surgical suture Figure 5 disposed shows a perspective representation of devices of the instant invention disposed on a ngid surgical support Modes for Carrying Out the Invention An embodiment of the device disclosed herein that has a radiographically detectable band provides means whereby the device can be located after implantation Thus, embodiments of the present invention may be formed with a band of a radiographically- detectable material such as gold, platinum or another appropriate high-atomic-number element deposited near the center on the external surface of the hollow-tube-shaped seed- substrate This band allows the visualization of the implanted device by standard radiographic procedures and allows the location and orientation to be accurately determined dunng treatment or in advance of surgery The radiographically detectable band may be apphed to entirely encircle the external surface of the hollow-tube-shaped seed-substrate at right-angles to the longitudinal axis of the seed The band may be 1 2 mm wide and be centrally positioned to allow accurate determination of the position of the seed by standard radiographic, fluoroscopic or computer-tomography visualization The band of radio-detectable material such as gold, platinum or another appropriate high-atomic-number element may be deposited by means similar to those described below for deposition of the radioactive source matenal In manufacturing one embodiment of the invention disclosed herein, a therapeutic radioisotope is deposited on the outward-facmg surface of the hollow-tube-shaped seed- substrate in such a manner as to produce an essentially uniform cylindrical radiation field in close proximity to the device The radioactive layer is then covered by a sealing layer, the purpose of which is to prevent the escape of a significant amount of the radioactive material into the surrounding living body The disposition of the radioactive source layer on the external surface of the hollow- tube-shaped seed-substrate may be varied to achieve different ends As example, the radioactive source layer may extend over the entire external surface of the hollow-tube- shaped seed-substrate and extend over a previously- applied radiographically detectable band In an alternative embodiment the radioactive source layer may be excluded from a region at each end of the external surface of the hollow-tube-shaped seed-substrate m order to provide a narrow non-radioactive ring at each end of the seed In a further embodiment, the radioactive source layer may extend over the entire external surface of the hollow-tube- shaped seed-substrate with the exception of the region that bears the radiographically detectable band An embodiment of the invention disclosed herein may have the central hollow-tube- shaped seed-substrate formed from a material essentially transparent to the radiation emitted by the therapeutic isotope Such materials may be elements such as titanium, carbon, tantalum, hafnium or zirconium or an alloy such as stainless-steel Alternatively, organic polymers may be used for fabrication of the hollow-tube-shaped seed-substrate and may be any of a number of materials such as polypropylene, polyethylene terephthalate, nylon, polyurethane, polyphenylene oxide blends, polyphenylsulfone, polysulfone, polyether sulfone, polyphenylene sulfide, phenyletheretherketone, polyetheπmide or liquid crystal polymers Such polymers and their sources are disclosed m Table 1 A further feature of embodiments of the invention is that the radioactive layer is covered by a sealing layer, the purpose of which is to prevent contact with the radioactive isotope and to prevent the escape of radioactive material into the surrounding living body The sealing layer may be a material essentially transparent to the radiation emitted by the therapeutic isotope, such as pyrolytic carbon deposited from a chemical vapor An alternative sealing layer such as titanium may be deposited from an atomic vapor A further embodiment of the sealing layer may comprise an organic coating, as for example a coating formed from a heat shrinkable plastic, a coating produced by solvent evaporation, a coating produced by a polymerization reaction or by molding plastic around the exterior of the device An optional feature of the invention disclosed herein is to provide a radiographically detectable band, desirably apphed near the median point of the long axis of the device with sufficient width and opacity to make the device visible and its orientation apparent on a radiograph taken of a patient following implantation of the device TABLE 1: ACCEPTABLE NONABSORBABLE POLYMERS WITH THEIR TRADE NAMES AND COMMERCIAL SOURCES Material Trade Names Sources Polyurethane Texm, Desmopan, Estane Bayer Corp , B F Goodnch Polypropylene Surgilene, Prolene Ethicon, American Cyanamid Polyethylene terephthalate Impet, Petra, Rymte, Estar Allied, Hoechst, Celanese, (PET) duPont, Eastman Polyphenylene oxide blends Noryl, Prevex General Electnc (PPO) Polyphenylsulfone (PPSU) Radel R Amoco Polysulfone (PSU) Udel, Ultrason S Amoco, BASF Polyether sulfone (PES) Radel A, Ultrason E Amoco, BASF Polyphenylene sulfide (PPS) Fortron, Ryton, Supec Hoechst, Celanese, Phillips, GE Phenyletheretherketone Kadel, Victrex Amoco, Victrex (PEEK) Polyethenmide (PEI) Ultem GE Nylon Nylon duPont Liquid crystal polymer (LCP) Vectra Hoechst, Celanese The lumen of the hollow-tube-shaped seed-substrate compnses a substantial proportion of the total diameter of the device In a preferred embodiment, the total wall thickness of the seed including the inner tube substrate, radioisotope source material layer, radiographically-detectable band if present and sealing layer is approximately 0 15 mm, and the lumen diameter is approximately 0 51 mm, large enough to admit the passage through it of suturing needles and sutures In other embodiments of the instant invention, the wall of the hollow-tube-shaped seed-substrate may be pierced transversely by one or more perforations In embodiments that have perforations through the wall of the tube, the perforations may be shaped and oriented in any direction in order to best serve the purposes disclosed below In embodiments of the device that are provided with perforations, the perforations provide access for body fluids to the lumen of the tube Perforations in the wall of the tube may also provide anchor points as tissue grows into the holes Perforations may desirably be in the range of 0 031 to 0 31 mm wide The hollow-tube-shaped seed-substrate of the instant invention may be made of titanium or other biocompatible metal or may be made of synthetic matenal such as plastic Where titanium or other biocompatible metal is used, the tubes may be formed by a standard cold-drawing processes to form metal tubes For example, hollow-tube-shaped seed-substrates of the instant invention may be made from ASTM B265-78 grade 2 titanium by forming tubular sections 4 5 mm in length, 0 57 mm in outside diameter and 0 5 mm mside diameter Such titanium tubes are available commercially in the U S A from the Uniform Tube Company, Collegeville, Pennsylvania 19426 Where the hollow-tube-shaped seed-substrate of the instant invention is made of plastic or synthetic material, the seed-substrate may be formed by extruding or molding the tube from the mass matenal in a manner suitable to the material being formed A number of engineenng plastics represent acceptable materials including polypropylene, polyethenmide, polyethylene terephthalate, nylon, polyurethane, polyphenylene oxide blends, polyphenylsulfone, polysulfone, polyether sulfone, polyphenylene sulfide, phenyletheretherketone, polyethenmide or liquid crystal polymers These mateπais are available from suppliers listed in Table 1 Other polymeric and plastic materials that are suitable for use in the present invention will be obvious to those skilled in art The radioactive source material of the instant invention is disposed as a layer on the external surface of the hollow-tube-shaped seed-substrate The instant invention differs in this respect from prior art brachytherapy devices In the prior art, brachytherapy devices are generally disclosed in which the radioactive source matenal is present in association with a pellet or rod contained withm an encapsulating chamber The structure of the instant invention is advantageous in that all components of the source, including the disposition of the radioactive source material and a radiographically detectable band, if present, are deposited onto the external surface of the structural member of the seed, the hollow-tube-shaped seed-substrate The central lumen of the seed-substrate is unobstructed, thus making the hollow design possible with all the subsequent advantages imparted by that design Designers of pnor art brachytherapy devices made use of internal components such as pellets or rods to provide a support for the radioactive source material of the seed In some prior art designs, radiographically-detectable markers were also encapsulated together with the radioactive source material The use of such internal components in pnor art designs requires an encapsulating chamber and precludes a hollow-tube-shaped seed design The radioactive source layer is apphed to the hollow-tube-shaped seed-substrate by any of a variety of conventional process such as sputtering, laser ablation, cathodic arc plasma deposition, curvilinear cathodic arc plasma deposition, vapor deposition, or electroplating Such known processes are further set forth in U S patent 5,342,238 to Good, the disclosure of which is hereby incorporated by reference For example, but not by way of limitation, the radioactive layer on the hollow-tube- shaped seed-substrate may be electroplated onto the external surface of the hollow-tube- shaped seed-substrate The exact method for apphcation of the layer depends upon the material to be deposited and the material of which the tube is constructed If the tube is constructed from a material which does not conduct electricity, such as a plastic, the outer surface must first be metallized to make it conducting This may be achieved by any one of several standard techniques commonly used in the plastics industry If the tube is constructed from a material difficult to electroplate, such as titanium, a surface pretreatment is required to obtain reliably-adherent electrodeposition of plating layers For example, a surface pretreatment procedure for titanium has been disclosed by Pratt Whitney Aviation that includes an abrasive blast, a hot alkaline cleansing in 30% potassium hydroxide, a hydrochloric acid pickle, a "bright dip" (achieved by dipping in an aqueous solution of 12% by volume acetic acid, 70% hydrofluoric acid and 1% nitric acid), an "anodic etch" for 6 minutes at 162 amperes per square meter (achieved in 13% by volume hydrofluoric acid, 83% acetic acid and 4% water), a "sulfate nickel strike" to an approximate thickness of 25 microinches followed by drying in air for 2 hours at 48 degrees C This process achieves deposition of a thin nickel layer onto the surface of the titanium, thus providing a more advantageous surface layer for electroplating If desired, a radiographically detectable band, for example a band of gold approximately 0 01 mm thick by 1 2 mm wide, deposited from a commercial electroplating solution (for example AuRoTechPl from AT&T Electroplating Chemicals and Services) can be deposited directly onto a previously-applied thm nickel layer applied as described above Embodiments of the instant invention may incorporate different therapeutic isotopes in order to achieve different therapeutic purposes and to achieve different activities For example, beta-particle emitting isotopes such as yttπum-90 and phosphorus-32 may be prepared with total activities of from 0 1 to 100 millicunes Beta-emittmg devices are anticipated to be used for therapy where relatively little penetration of the radioactivity is desired In other embodiments isotopes that emit electromagnetic radiation are used Such embodiments may have activities as high as 10 curies and are used in applications such as short-term applications of only a few minutes to prevent or inhibit the restenosis of blood vessels after angioplasty If the therapeutic radioisotope is palladιum-103, the radioactive source material layer may be deposited onto the hollow-tube-shaped seed-substrate by the method disclosed in U S patent 5,405,309 to Carden, the disclosure of which is hereby incorporated by reference This electroplating technology can provide apparent activities of from 0 1 to 300 millicunes per seed If the therapeutic radioisotope to be used is iodine- 125, a uniform layer of silver is first deposited onto the outer surface of the hollow-tube-shaped seed-substrate Any of the techniques cited above can be used for this purpose provided a uniform and adherent layer of approximately 0 025 mm thickness results The ιodme-125 is then chemisorbed onto the silver layer by the method disclosed in U S patent 4,323,055 to Kubiatowicz, the disclosure of which is hereby incorporated by reference This procedure can provide apparent seed activities of from 0 1 to 100 millicunes per seed The radioactive matenal layer may be deposited in a radioactive form such as the application of palladιum-103, ιodιne-125 or yttπum-90 Alternatively, a precursor isotope such as gold- 197, yttπum-89, ιndιum-191 or palladιum-102 may be deposited and then transmuted in situ, for example, by bombardment with neutrons, into the desired therapeutic isotope For example, yttnum-89 may be deposited on the outer surface of the hollow-tube-shaped seed-substrate by electroplating or otherwise depositing the yttπum-89, and yttnum-90 may be produced by bombardment with neutrons to transmute the non- radioactive isotope Gold-198 (generally referred to by this designation, though contaimng gold- 199 isotope as well), yttπum-90 and palladium- 103 may be produced by analogous processes The application of brachytherapy sources for the medical therapeutic application of radiation requires that the radioactive source be entirely sealed to prevent escape of the radioisotope This is essential to preclude the systemic distribution of the isotope within the patient and contamination of medical personnel, medical facilities and the general environment In the preferred embodiments of the instant invention, the entire radioisotope source layer is provided with a biologically-compatible, radiation-permeable, surface-sealing layer that entirely seals the external surface of the hollow-tube-shaped seed-substrate with the radioactive and radiographically detectable layers apphed thereon The sealing layer seals to the ends of the hollow-tube-shaped seed-substrate ensuring a hermetic seal The sealing layer prevents radioactive materials from escaping and provides a radioactive device which meets the normal definition of a "sealed source " In one embodiment the sealing layer may be made of a plastic material or any other biocompatible organic material, provided the material is adequately transparent to the therapeutic radiation and has sufficient durability to protect and retain the radioisotope Such a sealing layer will cover the entire external surface and the layers apphed thereon of the hollow-tube-shaped seed-substrate Such a sealing layer may be made from a heat shnnkable plastic, or from a coating formed by solvent evaporation or polymerization reaction, or by molding plastic around the exterior of the device The adiacent ends of the outer sealing layer and the hollow-tube seed-substrate are joined by the process of applying the sealing layer In another embodiment the sealing layer may be made of a plastic material or any other biocompatible organic material, provided the material is adequately transparent to the therapeutic radiation and has sufficient durability to protect and retain the radioisotope Such a sealing layer will have the form of an outer tube that covers the entire external surface and the layers applied thereon of the hollow-tube-shaped seed-substrate Such a sealing layer may be made from any of a number of plastics shown in Table 1 The adjacent ends of the outer sealing tube and the hollow-tube seed-substrate may be joined by one of several processes For example they may be joined by glumg, heat sealing, ultrasonic welding or solvent welding Manufactured devices are tested for physical integrity and leakage, following the appropriate standard as for example, ANSI-44 2 1973, ANSI-542 1977 and/or ISO-2919 These test standards ensure that devices comply with the requirements to be defined as sealed sources by testing for physical integrity and leakage In another embodiment the sealing layer can be made of titanium, hafnium or zirconium metal or other suitable biocompatible metal that is adequately transparent to the therapeutic radiation Such a sealing layer will seal to the ends of the hollow-tube-shaped seed-substrate and cover the entire external surface and the layers applied thereon of the hollow-tube-shaped seed-substrate This sealing layer may be applied as a hollow tube which is swaged and bonded on each end of the hollow tube seed substrate In an alternative embodiment, the sealing layer may be applied as a layer of metal deposited by any of the means cited above to form the radioactive layer In yet another embodiment the sealing layer can be made of a layer of titanium carbide, titanium nitride, titanium carbonitπde, hafnium nitride, or zirconium nitride as disclosed by Good, or be made of another suitable biocompatible metal or metal compound that is adequately transparent to the therapeutic radiation Such a sealing layer will cover the entire external surface and the layers applied thereon and seal to the ends of the hollow- tube-shaped seed-substrate or the internal surface of the hollow-tube-shaped seed-substrate in a manner that suffices to meet the objectives of the instant invention A detailed description of a particular embodiment of the instant invention is made by reference to Figure la and lb The embodiment of the instant invention disclosed in Figure la comprises a novel brachytherapy seed-substrate that has the form of a hollow tube open on both ends and having an internal surface 102 and external surface 103 The hollow- tube-shaped seed-substrate 101 of the device 100 may be made of titanium or other biocompatible metal or may be made of synthetic material such as plastic The radioactive source material 104 is disposed as a uniform layer on the external surface 103 of the device The radioactive layer 104 thus has the form of a cylinder disposed upon the external surface 103 of the hollow-tube-shaped seed-substrate 101 A radiographically detectable layer 105 is shown layered on a portion of the external surface 103 of the hollow-tube-shaped seed- substrate The radiographically detectable layer 105 is thus similarly in the form of a cylinder on the external surface 103 of the hollow-tube-shaped seed-substrate 101 disposed at right-angles to the long axis of the seed-substrate The entire device 100 is provided with a biologically-compatible, radiation-permeable, surface-sealing layer 106 that entirely covers and seals the radioactive layer 104, the radiographically detectable layer 105 and the ends of the hollow-tube-shaped seed device The biologically-compatible, radiation-permeable, surface-sealing layer 106 is apphed by a process such as shrink-wrapping and forms a seal 107 to the hollow-tube-shaped seed-substrate 101 The lumen of the device 108 is shown Figure lb shows the details of the hollow-tube-shaped seed-substrate 101 open at an end and having an internal surface 102 and an external surface 103 The radioactive layer 104 is shown as a uniform layer on the external surface 103 of the device 100 The device 100 is provided with a biologically-compatible, radiation-permeable, surface-sealing layer 106 that entirely covers and seals the radioactive layer 104 and the end of the device 100 The biologically-compatible, radiation-permeable, surface-sealing layer 106 is apphed by a process such as shrink-wrapping and forms a seal 107 to the tube-shaped seed-substrate 101 The lumen of the device 108 is shown Figures 2a and 2b show a diagrammatic representation of a cross-section of an embodiment of the instant invention that is formed with a perforation 209 through the wall of the device 200 and is sealed with an electroplated sealing layer 206 The cross-section shows a portion of the hollow-tube-shaped seed-substrate 201 and its internal surface 202 and its external surface 203 The diagram shows the location of the radioactive layer 204 upon the external surface 203 of the hollow-tube-shaped seed-substrate 210 and the radiographically detectable layer 205 also disposed upon the external surface 203 of the hollow-tube-shaped seed-substrate 201 The radioactive layer 204 is excluded from the terminal portion 207 of the external surface 203 of the hollow-tube-shaped seed-substrate 201 The diagram shows the sealmg-layer 206 covenng the radioactive layer 204, the radiographically detectable layer 205 and the external surface 203 of the hollow-tube-shaped seed-substrate 201 The seal 207 between the electroplated sealing layer 206 and the end 210 of the hollow-tube-shaped seed-substrate 201 is shown Figure 2b shows a diagrammatic representation of the detail of a cross-section of an end of a device 200 of the instant invention that is formed with a electroplated sealing layer 206 The cross-section shows a portion of the hollow-tube-shaped seed-substrate 201 and its internal surface 202 and its external surface 203 The diagram shows the location of the radioactive layer 204 upon the external surface 203 of the hollow-tube-shaped seed-substrate 201 The diagram shows the sealmg-layer 206 covering the radioactive layer 204 The end 207 of the hollow-tube-shaped seed-substrate 201 from which the radioactive layer 204 is excluded is shown, together with the seal 210 between the sealing layer 206 and the end 207 of the hollow-tube-shaped seed-substrate 201 A novel feature of an embodiment of the brachytherapy device disclosed herein is the external tube that is swaged and laser welded to the hollow-tube-shaped seed-substrate shown in Figures 3a and 3b In Figure 3a a diagrammatic cross section of a complete hollow-tube device 300 with an external sealing tube 311 is shown The cross-section shows the hollow-tube-shaped seed-substrate 301, its internal surface 302 and its external surface 303 The diagram shows the location of the radioactive layer 304 upon the external surface 303, the location of the hollow-tube-shaped seed-substrate 301 and that of the radiographically detectable layer 305 also disposed upon the external surface 303 of the hollow-tube device 300 The diagram shows the outer seahng-layer 311 enclosing the radioactive layer 304 and the radiographically detectable layer 305 The end of the hollow- tube device 300 showing the swaged region 312 and laser-welded region 313 is shown Figure 3b is a diagrammatic representation of a cross-section of the swaged and laser welded end of double-walled tube device shown in Figure 3a The cross-section shows the end of the tube-shaped seed-substrate 301 and its internal surface 302 and its external surface 303 The diagram also shows the location of the radioactive layer 304 upon the external surface 303 of the hollow-tube-shaped seed-substrate 301 The outer seahng-layer 311 is shown enclosing the radioactive layer 304 The swaged region 312 and the laser- welded region 312 at the end of the sealed device is shown A particular utility of the hollow-tube-shaped brachytherapy device disclosed herein is its ability to be surgically sewn into position by sutures or rigid elements passed through the lumen of the device Figure 4 shows a perspective representation of a device 401 and a portion of a second device 402 of this invention disposed on a suture 403 Figure 5 shows a view of a device of this invention 504 shown disposed on a rigid surgical support 505 as the device would be used in practice

Claims: Claims What is claimed is 1 A brachytherapy device for implanting radiation-emitting material within a living body, comprising a tubular support having two open ends, radiation-emitting material on an external surface of said tubular support, means for sealingly encasing said radiation-emitting material so as to prevent contact between bodily fluids and said radiation-emitting material of said brachytherapy device 2 The brachytherapy device of claim 1, for implanting radiation-emittmg matenal within a living body, wherein said tubular support compπses a hollow-tube-shaped seed-substrate member, said member having a lumen, an internal surface adjacent to said lumen and an external surface, said lumen being open at a first end and at a second end, said external surface having disposed thereon said radiation-emittmg matenal, said radiation-emitting matenal being selected from isotopes of the group consisting of ιodιne-125, palladιum-103, ιπdιum-192, gold-198, yttrmm-90 and phosphorus-32, and said lumen being adapted for fixing means to be threadedly passed in at said first end, through said lumen and out at said second end, whereby the brachytherapy device is fixable in a patient by said fixing means at a site where brachytherapy is desired to be applied 3 The brachytherapy device of claim 2, wherein said hollow-tube-shaped seed-substrate member compnses a material selected from the group consisting of titanium, carbon, stainless-steel, tantalum, hafnium and zirconium 4 The brachytherapy device of claim 2, wherein said hollow-tube-shaped seed-substrate member comprises a material selected from the group consisting of polypropylene, polyethylene terephthalate, nylon, polyurethane, polyphenylene oxide blends, polyphenylsulfone, polysulfone, polyether sulfone, polyphenylene sulfide, phenyletheretherketone, polyethenmide and liquid crystal polymer 5 The brachytherapy device of claim 2, wherein said radiation-emitting material being a quantity having an activity of between 0 1 and 10,000 milhcurie 6 The brachytherapy device of claim 5, wherein said radiation-emitting material comprises a material selected from the group consisting of palladιum-103, indium- 192, ιodme-125, gold-198, yttπum-90 and phosphorus-32 7 The brachytherapy device of claim 2, additionally comprising a band detectable by radiography disposed on said external surface and located essentially centrally relative to the long axis of said hollow-tube-shaped seed- substrate, said band having sufficient width and radiopacity to make said hollow-tube- shaped seed-substrate detectable and its orientation determinable by radiological examination, whereby the presence and orientation of the hollow-tube-shaped seed-substrate may be determined by radiological examination in a patient receiving brachytherapy with a hollow- tube-shaped seed-substrate device 8 The brachytherapy device of claim 7, wherein said sealingly encasing means comprises a sealing layer being sealingly disposed about said hollow-tube- shaped seed-substrate to entirely enclose said external surface and said radioactive layer and said radiographically detectable band disposed thereon 9 The brachytherapy device of claim 8, wherein said sealing layer comprises a matenal selected from the group consisting of titanium, carbon, stainless-steel, tantalum, hafnium, zirconium, titanium carbide, titanium nitride, titanium carbonitπde, hafnium nitride, and zirconium nitnde 10 The brachytherapy device of claim 8, wherein said sealing layer comprises a seahng-mateπal essentially transparent to the radiations emitted by the radiation-emitting material, and wherein said seahng-mateπal comprises an organic coating around the exterior of the device, wherein said organic coating is applied by a process selected from the group consisting of heat shrinking a plastic layer, depositing a plastic layer by solvent evaporation, depositing a plastic layer by a polymerization reaction and molding a plastic layer 11 The brachytherapy device of claim 8, wherein said sealing layer compnses an outer tube comprising seahng-mateπal essentially transparent to the radiations emitted by the radiation-emitting matenal, wherein said outer tube is snugly fitted over said hollow tube with said band and said radiation-emitting material deposited thereon on said outward facing surface, wherein said outer tube comprises a metal selected from the group consisting of titanium, stainless-steel, tantalum, hafnium and zirconium, wherein adjacent ends of said metal outer tube and said hollow-tube are swaged together and joined by laser welding so as to form a sealed device, whereby a sealed brachytherapy device is formed 12 The brachytherapy device of claim 8, wherein said sealing layer compπses an outer tube comprising sealmg-mateπal essentially transparent to the radiations emitted by the radiation-emitting matenal, wherein said outer tube is snugly fitted over said hollow tube with said band and said radiation-emitting material deposited thereon on said outward facing surface, wherein said outer tube comprises a plastic selected from the group consisting of polypropylene, polyethylene terephthalate, nylon, polyurethane, polyphenylene oxide blends, polyphenylsulfone, polysulfone, polyether sulfone, polyphenylene sulfide, phenyletheretherketone, polyethenmide and liquid crystal polymer, and wherein adjacent ends of said plastic outer tube and said hollow-tube are joined by a process selected from the group consisting of gluing, heat sealing, ultrasonic welding and solvent welding, whereby a sealed brachytherapy device is formed 13 A brachytherapy device for implanting radiation-emitting material with a living body, comprising a tube-shaped seed-substrate having two open ends and being pierced by a plurahty of perforations, radiation-emitting material on an external surface of said tubular support, means for sealingly encasing said radiation-emitting material so as to prevent contact between bodily fluids and said radiation-emitting material of said brachytherapy device, whereby said plurality of perforations permits bodily fluids and cells ready access to said lumen of said brachytherapy device thereby promoting tissue growth in and around said brachytherapy device 14 The brachytherapy device of claim 13, wherein said tube-shaped seed-substrate compπses a hollow tube open at both ends and having a lumenal surface and an outward facing surface, wherein a radiation-emitting material is deposited on said outward facing surface in a manner as to produce an essentially uniform cylindrical radiation field in close proximity to said brachytherapy device, wherem a band detectable by radiography is disposed on said outward facing surface and is located essentially centrally relative to the long axis of said hollow tube, said band having sufficient width and radiopacity to make said hollow tube detectable and its orientation determinable by radiological examination, said radiation-emitting matenal and said band being sealingly encased by a sealing layer such that the escape of said radiation-emitting material is prevented, whereby a therapeutic dose of radiation may be delivered to a spatially well defined and limited volume of diseased tissue within a living body of a patient undergoing brachytherapy without leakage of radioactive matenal into said patient 15 The brachytherapy device of claim 13, wherein said radiation-emitting material compπses a material selected from the group consisting of palladιum-103, indium- 192, ιodιne-125, gold- 198, yttπum-90 and phosphorus-32, and wherein said radiation-emitting material is of a quantity having an activity of between 0 1 and 10,000 milhcuπe 16 The brachytherapy device of claim 13, in which said hollow tube is formed from a material essentially transparent to the radiation emitted by the therapeutic isotope 17 The brachytherapy device of claim 13, wherem said sealing layer comprises a sealmg-matenal essentially transparent to the radiation emitted by the radiation-emitting material, and wherein said seahng-mateπal comprises pyrolytic carbon, and said seahng-mateπal is deposited from a chemical vapor 18 The brachytherapy device of claim 13, wherein said sealing layer compnses a sealmg-matenal essentially transparent to the radiations emitted by the radiation-emittmg matenal, and wherein said sealing layer comprises titanium, and said seahng-mateπal is deposited by means selected from the group consisting of atomic vapor deposition and electroplating 19 A brachytherapy device compπsing a tubular support having a lumenal surface and an external surface and two open ends, radiation-emitting material on said external surface of said tubular support, means for sealingly encasing said radiation-emittmg matenal so as to prevent contact between bodily fluids and said radiation-emitting material of said brachytherapy device, and fixing means that can be passed through said hollow-tube in such a way as to fixedly locate said hollow-tube, said fixing means is a surgical fixative being selected from suture material or rigid surgical fixative rods, whereby said brachytherapy device is fixedly locatable relative to other similar brachytherapy devices, relative to the tumor to be treated or relative to the treatment volume to be irradiated 20 The brachytherapy device of claim 19, additionally comprismg a band detectable by radiography disposed on said external surface and located essentially centrally relative to the long axis of said tubular support, said band having sufficient width and radiopacity to make said hollow tube detectable and its oπentation determinable by radiological examination, said radiation-emitting matenal and said band being sealingly encased by a sealing layer such that the escape of said radiation-emitting material is prevented, whereby said brachytherapy device is fixedly locatable relative to other similar brachytherapy devices, relative to the tumor to be treated or relative to the treatment volume to be irradiated, whereby a therapeutic dose of radiation may be delivered to a spatially well defined and limited volume of diseased tissue within a living body of a patient undergoing brachytherapy without leakage of radioactive material into the patient, and whereby the location and orientation of said brachytherapy device may be monitored by radiologic examination 21 The brachytherapy device of claim 19, wherein said radiation-emitting material compnses a material selected from the group consisting of palladium- 103, indium- 192, ιodιne-125, gold-198 yttnum-90 and phosphorus-32, and wherein said radiation-emitting material being of a quantity havmg an activity of between 0 1 and 10,000 milhcurie 22 A precursor device adapted to be transmuted into brachytherapy device comprising a hollow-tube-shaped seed-substrate having two open ends, a layer of an isotope on an outer surface of said hollow-tube-shaped seed- substrate, said isotope being selected from the group consisting of gold- 197, lπdium- 191, palladιum-102, phosphorus-31 and yttnum-89, means for sealingly encasing said isotope so as to prevent contact between bodily fluids and said isotope of said precursor device and to yield a sealed precursor device 23 A method for producing a brachytherapy device from the precursor device of claim 22, comprising irradiating said sealed precursor device with neutrons by means of an irradiator selected from the group consisting of a nuclear reactor, and a cyclotron, so as to transmute said isotope to a radiation-emitting isotope A method for using a hollow-tube brachytherapy device compnsing threadedly inserting through a lumen of a hollow-tube brachytherapy device a member selected from the group consisting of surgical wire and surgical plastic filament, fixedly attaching said hollow-tube brachytherapy device upon said member, attaching said hollow-tube brachytherapy device to a catheter by means of said member, and inserting said catheter threadedly or surgically mto a patient at a site where brachytherapy is desired to be delivered A method of using a hollow-tube brachytherapy device compπsing threadedly inserting a surgical suture through a lumen of a hollow-tube brachytherapy device, fixedly attaching said hollow-tube brachytherapy device upon said suture, surgically attaching said hollow-tube brachytherapy device into a patient at a site where brachytherapy is desired to be delivered

Inventors: CONIGLIONE ROY, CONIGLIONE, ROY
Applicants: CONIGLIONE ROY, IBT TECHNOLOGY PARTNERS, CONIGLIONE, ROY
Application year: 1996
Main classification: A61N5
IPC codes: A61F2, A61K31, A61K51, A61M36, A61N5, A61P35, G21G4